Ad
related to: amerisourcebergen abc nyse futurestradestation.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
AmerisourceBergen Corporation ( NYSE:ABC ) will increase its dividend from last year's comparable payment on the 28th...
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials. AmerisourceBergen (ABC) is an Incredible Growth Stock: 3 Reasons Why Skip to ...
Let's see if AmerisourceBergen Corporation (ABC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AmerisourceBergen's (ABC) fiscal third-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AmerisourceBergen (ABC) possesses solid growth attributes, which could help it handily outperform the market.
Ad
related to: amerisourcebergen abc nyse futurestradestation.com has been visited by 10K+ users in the past month